ルワンダのキング・ファイサル病院の慢性B型およびC型肝炎患者の肝臓弾性鏡検査の結果
François Xavier Niyitegeka1, Florien Ndagijimana2, Emile Twagirumukiza3,4
1King Faisal Hospital Rwanda, Kigali, Rwanda. francisxavier.n.hapin@gmail.com.
Journal of ultrasound
|February 13, 2026
まとめ
肝臓のエラストグラフィは,ルワンダの慢性肝炎BおよびC患者の肝繊維症を正確に評価します. 高度な線維症は,C型肝炎においてより一般的であり,高齢化とより長い感染期間が主要な予測因子である.
科学分野:
- 肝臓病理学 肝臓病理学
- メディカルイマージング (医学イメージング)
- ウイルス学 ウイルス学 ウイルス学
背景:
- 肝臓のエラストグラフィは,肝臓線維症と肝硬変の診断のための非侵襲的方法です.
- 慢性B型肝炎 (CHB) と慢性C型肝炎 (CHC) は,肝疾患と肝細胞癌 (HCC) の主要な原因です.
- ルワンダにおける肝臓のエラストグラフィの発見に関するデータは限られている.
研究 の 目的:
- キング・ファイサル病院のCHBおよびCHC患者における肝乳腺検査の発見を記述する.
- B型肝炎とC型肝炎のエラストグラフィーの結果を比較する.
- 人口統計学/臨床的要因と線維症の重症度の間の相関を評価する.
主な方法:
- 149人のCHBとCHC患者の横断的な研究.
- ポイント・シャー・ウェーブ・エラストグラフィー (pSWE) で測定された肝硬さ.
- 人口統計データ,肝機能検査,ウイルス負荷,および線維症のステージングが収集され,分析されました.
主要な成果:
- 重度の線維症 (F3-F4) は,CHC (72%) の患者ではCHB (28%) の患者よりもより一般的であった (p=0.011).
- 高齢 (>40歳) は,進行性線維症の強い予測因子であった (OR=10.3,p=0.002).
- 感染期間が長くなり,肝硬化症,異常なウイルス負荷,抗ウイルス治療の欠如が,線維症の有意な予測要因であった.
結論:
- ヘパティック・エラストグラフィは,CHBおよびCHCにおける肝繊維症の評価のための信頼性の高い非侵襲的ツールです.
- 高度な線維症は,CHC患者でより一般的です.
- 年齢,感染期間,ステアトーシス,ウイルス負荷,治療状態などの臨床的要因は,繊維症の重症度と相関し,資源の限られた環境での弾性撮影の有用性を支持しています.
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
255
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
255
Hepatic Drug Excretion: Influencing Factors
609
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
609
Hepatic Drug Clearance: Role of Transporters
312
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
312
Hospitals-II
1.2K
Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
Nurses that work in...
1.2K


